ClinicalTrials.gg
Sign In

Drug

ABT751 clinical trials

Also written ABT-751.

studies test it
12
open now
0
in phase 3
0
first study started
2002

How studies write it

Studies that test it under each name

Development codes

ABT-751
11

Combined with it in one product

ABT-751 and Carboplatin
1
Paraplatin
1

Studies by the year they started

12 studies that test it; most in 2002 (3)

Studies that test ABT751, by start year
YearStudies
20023
20033
20042
20062
20072

By phase

A phase 1/2 study counts in both.

Phase 1
7
Phase 2
10

What it is tested for

Each study’s main condition, where its own words name it.

Carcinoma, Non-Small-Cell Lung
3
Neuroblastoma
1
Hematologic Neoplasms
1
Neoplasms
1
Carcinoma, Renal Cell
1
Breast Neoplasms
1
Colorectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Lung Neoplasms
1
Prostatic Neoplasms
1

Who runs them

Industry 6 · Other 6

Abbott (5) · Children's Oncology Group (1) · M.D. Anderson Cancer Center (1) · AbbVie (prior sponsor, Abbott) (1) · National Institutes of Health Clinical Center (CC) (1) · Therapeutic Advances in Childhood Leukemia Consortium (1) · Konstantin Dragnev (1) · Vanderbilt-Ingram Cancer Center (1)

Often tested with

Tested in the same studies.

Dexamethasone (1) · Pegaspargase (1) · Doxorubicin (1) · Carboplatin (1)

Studies

Open first, then newest update. How each study uses ABT751 is read from its arms, and is right about nine times in ten.

Testing it · 12